A New Paradigm for Resolving
Over the last two decades, scientists have elucidated the critical immunoregulatory role of omega-3 fatty acids and their conversion into Resolvins and other pro-resolving lipids that are potent agonists of inflammation resolution and tissue repair.
Our HEALER technology enables the pharmaceutical development of bioactive lipids as new molecules with enhanced stability, bioavailability, formulation properties, and patent protection.
"We are committed to creating innovative products that improve the lives of patients suffering from gastrointestinal diseases."
- Frank C. Sciavolino, Ph.D., Founder and Chief Scientific Officer